Official Title
The Impact of COVID-19 on Pulmonary Procedures: A Nationwide Survey
Brief Summary

This study investigates the changes in practice by pulmonary procedural programs across the United States as they faced the coronavirus pandemic. Information gathered from this study may help guide pulmonary programs on a wider scale and improve their practice. The study may also help researchers understand where they should focus research efforts to better respond to a pandemic in the future.

Detailed Description

PRIMARY OBJECTIVE:

I. To assess how pulmonary medicine programs adapted their procedural practices and
techniques, ambulatory operations, and provider staffing in response to the coronavirus-2019
(COVID-19) epidemic.

OUTLINE:

Participants complete survey over 5-10 minutes.

Recruiting
Covid-19 Infection
Hematopoietic and Lymphoid Cell Neoplasm
Malignant Solid Neoplasm

Other: Survey Administration

Complete survey

Eligibility Criteria

Inclusion Criteria:

- Pulmonologists that are members of the American Association of Bronchology and
Interventional Pulmonology (AABIP) and/or the American College of Chest Physicians
(ACCP)

- These organizations were chosen because their member databases are composed of
pulmonologists in the United States (U.S.) that perform the pulmonary procedures
described in this survey. Letters of approval will be obtained from these
organizations and provided to the MD Anderson Institutional Review Board (IRB). Once
the MD Anderson IRB approves this survey study, the survey will be sent to the
relevant subcommittees of these organizations for their electronic dissemination to
their membership

Exclusion Criteria:

None

Eligibility Gender
All
Eligibility Age
Minimum: N/A ~ Maximum: N/A
Countries
United States
Locations

M D Anderson Cancer Center
Houston, Texas, United States

Investigator: Bruce F. Sabath
Contact: 240-476-8938
bsabath@mdanderson.org

Investigator: Bruce F. Sabath

Bruce F Sabath, Principal Investigator
M.D. Anderson Cancer Center

M.D. Anderson Cancer Center
NCT Number
MeSH Terms
COVID-19
Neoplasms